PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Eikelboom, John W.
TI  - Data from New Oral Anticoagulants Provide Clues for Future Drug Development
DP  - 2013 Sep 01
TA  - MD Conference Express
PG  - 4--5
VI  - 13
IP  - 13
4099  - http://mdc.sagepub.com/content/13/13/4.short
4100  - http://mdc.sagepub.com/content/13/13/4.full
AB  - The new oral anticoagulants have delivered promising results in terms of efficacy and safety. However, the data from the many clinical trials that have evaluated the new agents has provided physicians with a wealth of information for future drug development. This article presents five lessons learned from the recent clinical trials that evaluated the novel oral anticoagulant agents, including dabigatran, rivaroxaban, and apixaban.